Try our Advanced Search for more refined results
Health
Health Law360 provides breaking legal news and analysis on the health care industry. Coverage includes litigation, policy developments, and corporate deals involving health care services companies such as hospitals, health insurers, physicians groups, and medical suppliers.
Sign up for a 7-day FREE trial today!
Latest News in Health
-
April 15, 2026
Larry King's Estate Says Supplement Co. Still Using His Name
Larry King's estate sued operators of a prostate health supplement company in California state court Wednesday, alleging they continued using his name and likeness to advertise their product even after striking a legal settlement agreeing to stop.
-
April 15, 2026
'A Bunch Of Games': MDL Judge Irked By Meta, AGs Sparring
A California federal judge appeared skeptical Wednesday of Meta Platforms Inc.'s request for a summary judgment win over claims by state attorneys general in multidistrict social media addiction litigation, saying repeatedly that many disputes should be resolved at trial and panning some arguments by both sides as "a bunch of games."
-
April 15, 2026
Hims & Hers Providers Can't Duck Suit Over Student's Suicide
Medical providers for telehealth company Hims & Hers can't escape a wrongful death lawsuit from the family of a Washington State University freshman who died by suicide in 2023, according to a Washington state judge's order denying summary judgment motions from five individual defendants.
-
April 15, 2026
Amneal Trims But Can't Nix AGs' Drug Price-Fixing Suit
There is enough evidence from which a jury could conclude that Amneal Pharmaceuticals participated in a conspiracy to fix the price of an epilepsy medication, but not enough to show it participated in the overarching antitrust conspiracy alleged by dozens of state attorneys general, a Connecticut federal judge ruled Wednesday.
-
April 15, 2026
Drugmaker Aquestive's Brass Sued Over FDA Setback
Executives and directors of pharmaceutical company Aquestive Therapeutics Inc. were hit with a shareholder's derivative suit Wednesday accusing them of ignoring deficiencies in a research study for Aquestive's allergic reaction treatment, which eventually prompted the U.S. Food and Drug Administration to reject the company's new drug application.
Areas of Coverage
- AGENCIES
- U.S. Department of Health and Human Services
- Centers for Medicare and Medicaid Services
- State and international health care regulators
- POLICY & REGULATION
- Affordable Care Act
- Health Insurance Portability and Accountability Act
- Patient’s Bill of Rights
- Stark Law
- Consumer protection controls
- Tax-related issues
- Health care lobbying
- State and international health care legislation and regulation
- ENFORCEMENT
- Health care fraud investigations
- Merger reviews
- LITIGATION
- Medical malpractice and liability suits
- Mass torts
- Health care fraud disputes
- Insurance coverage suits
- Reimbursement disputes
- Whistleblower and anti-corruption compliance suits
- Antitrust suits
- Breach of contract suits
- Labor and employment issues
- Shareholder disputes
- Bankruptcy proceedings
- TRANSACTIONS
- Mergers, acquisitions, and joint ventures
- Health care project finance and real estate deals
- PROFILES
- Personnel moves
- Profiles of health attorneys
Readership
- Health care lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the health care services industry
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals